mHealth at the Heart of Discussion with Policy Makers at eHealth Week and mHealth Summit Europe

mHealth Summit Europe11 - 12 May 2015, Riga, Latvia.
The mHealth community will get a unique opportunity to influence the future of mHealth in Europe at eHealth Week and at the second annual mHealth Summit Europe. The event, which has 'Energising the mHealth Agenda in Europe' as its theme, kicks off eHealth Week - Europe's largest pan-European conference. Consultation results from the European Commission's Green Paper on mHealth will be presented at a plenary organised jointly by the Latvian Presidency, European Commission (EC) and HIMSS Europe, where follow-up actions will be discussed with panellists and the audience.

Peteris Zilgalvis, Head of Unit at the health and well-being unit of DG CONNECT, European Commission speaking on the mHealth Green Paper said: "The consultation has brought up some key issues for mHealth app developers, policy makers and end users alike - and the eHealth Week and mHealth Summit Europe will prove critical in determining the next steps."

More than 200 separate responses were received as part of this public consultation, which took place April-July, 2014. Of those that responded - from both inside and outside the EU - 97 said that strong privacy and security tools, such as data encryption and authentication mechanisms, were needed to build users' trust in mHealth; half called for a strengthened enforcement of data protection and the rules applicable to mHealth devices and nearly half demanded more patient safety and transparency of information, by means of certification schemes or quality labelling of lifestyle and wellbeing apps, with others warning against the risks of over-regulation. See the summary report of the Green Paper on mHealth Consultation here.

"The co-location of eHealth Week and mHealth Summit is no coincidence," said Rainer Herzog, Managing Director, HIMSS Europe, which co-hosts the event with the Personal Connected Health Alliance (PCHA). "As the eHealth market continues to develop and with the global mHealth market set to reach €19.77 billion by 2017 and Europe expected to become the largest market for mHealth in 2018 - the timing for this international thought leadership event could not be better."

Herzog added: "This summit will provide a crucial opportunity for the mHealth community to discuss the future of mHealth in Europe and decide on ways forward," says Rainer Herzog. "HIMSS, in its role as a global thought leader in this arena, is pleased to be part of this."

Taking place during the eHealth week under the auspices of the Latvian Presidency of the Council of the European Union, the mHealth Summit Europe 2015 welcomes principal stakeholders of the mHealth world from public and private healthcare sectors, clinicians, hospital and IT managers and VIP guests. The Summit will also address the role of regulation and standardisation in supporting innovation and creating trust and will explore national governments' roles in embedding mHealth in national health policies.

For further information, please visit:
http://www.mhealthsummit.eu

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a part of HIMSS WorldWide, a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS WorldWide encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS WorldWide, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

Bayer Grants4Apps® Dealmaker Berlin 2017

Bayer Grants4Apps® is calling all mature teams, startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and Grants4Apps' experts...